Skip to main content
Evaluation of ERCC1 and RRM1 as prognostic biomarkers in urothelial cancer (UC) treated with adjuvant platinum and gemcitabine chemotherapy. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Harshman, L. C., Bepler, G., Quinn, D. I., McKenney, J., Hawes, D., Simon, N., Srinivas, S., Dorff, T. B. AMER SOC CLINICAL ONCOLOGY. 2012

View details for Web of Science ID 000318009803271